U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
Show Filters
Hide Filters
Development Status
Other
109
Possibly Marketed Outside US
20
Investigational
2
US Previously Marketed
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Approval Year
Unknown
112
2020
3
2012
2
2013
2
2016
2
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Substance Class
Structurally Diverse
132
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
GInAS Tag
KEW
58
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Code System
FDA UNII
132
GRIN
122
NCBI TAXONOMY
116
Catalogue of Life
109
MPNS
100
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Substance Form
Principal Form
132
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Family
Rutaceae
Showing
111 - 120
of
132
results
Search within data set
First page
Previous page
1
2
11
12
13
14
Next page
Next page
Sort By
Approval Year, Recent
Approval Year, Oldest
Relevance
Display Name, A-Z
Display Name, Z-A
Least References
Most References
Oldest Change
Newest Change
AGATHOSMA CRENULATA WHOLE
MORE DETAILS
B6642J883V
Status:
Other
Class:
STRUCTURALLY DIVERSE
ZANTHOXYLUM AMERICANUM WHOLE
MORE DETAILS
NCL1TT8GSN
Status:
US Previously Marketed
First marketed in 1921
Class:
STRUCTURALLY DIVERSE
NARINGI CRENULATA WHOLE
MORE DETAILS
3G168G2S4C
Status:
Possibly Marketed Outside US
First approved in 2023
Class:
STRUCTURALLY DIVERSE
ZANTHOXYLUM FAGARA WHOLE
MORE DETAILS
9HFA7UZ0U9
Status:
Possibly Marketed Outside US
First approved in 2023
Class:
STRUCTURALLY DIVERSE
LIMONIA ACIDISSIMA WHOLE
MORE DETAILS
MU5C4X2819
Status:
Possibly Marketed Outside US
First approved in 2022
Class:
STRUCTURALLY DIVERSE
CITRUS RETICULATA WHOLE
MORE DETAILS
O0OX7CMF92
Status:
Possibly Marketed Outside US
First approved in 2021
Class:
STRUCTURALLY DIVERSE
CITRUS PARADISI WHOLE
MORE DETAILS
3FNT9K2294
Status:
Possibly Marketed Outside US
First approved in 2021
Class:
STRUCTURALLY DIVERSE
GLYCOSMIS CITRIFOLIA WHOLE
MORE DETAILS
K1Z43JI31W
Status:
Possibly Marketed Outside US
First approved in 2020
Class:
STRUCTURALLY DIVERSE
Citrus bergamia whole
MORE DETAILS
14YV5375VD
Status:
Possibly Marketed Outside US
First approved in 2020
Class:
STRUCTURALLY DIVERSE
CITRUS MEDICA WHOLE
MORE DETAILS
944U5Z3O5B
Status:
Possibly Marketed Outside US
First approved in 2020
Class:
STRUCTURALLY DIVERSE
Showing
111 - 120
of
132
results
Search within data set
First page
Previous page
1
2
11
12
13
14
Next page
Next page